Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pancreatitis

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 19 articles: HTML format

Single Articles

May 2026
1. O'REILLY EM, Wainberg ZA, Hendifar AE, Borad MJ, et al
   Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
   N Engl J Med. 2026 May 31. doi: 10.1056/NEJMoa2605555.
   PubMed     Abstract available
   
   
   
2. DER CJ, Yeh JJ
   Advances in RAS Therapeutics for Pancreatic Cancer.
   N Engl J Med. 2026;394:1857-1861.
   PubMed    
   
   
   
3. WOLPIN BM, Park W, Garrido-Laguna I, Spira A, et al
   Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer.
   N Engl J Med. 2026;394:1790-1802.
   PubMed     Abstract available
   
   
   April 2026
4. MARSTON NA, Bergmark BA, Sabatine MS
   Olezarsen for Hypertriglyceridemia and Pancreatitis Risk. Reply.
   N Engl J Med. 2026;394:1763-1764.
   PubMed    
   
   
   
5. WANG S, Fan Z
   Olezarsen for Hypertriglyceridemia and Pancreatitis Risk.
   N Engl J Med. 2026;394:1763.
   PubMed    
   
   
   
6. CHEN R, Lu S, Chen M
   Olezarsen for Hypertriglyceridemia and Pancreatitis Risk.
   N Engl J Med. 2026;394:1762.
   PubMed    
   
   
   March 2026
7. TU ZL, Tu JF
   Walled-Off Pancreatic Necrosis.
   N Engl J Med. 2026;394:e22.
   PubMed    
   
   
   
8. PARK W, Kasi A, Spira AI, Paz-Ares Rodriguez L, et al
   Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer.
   N Engl J Med. 2026 Mar 25. doi: 10.1056/NEJMoa2600752.
   PubMed     Abstract available
   
   
   November 2025
9. MARSTON NA, Bergmark BA, Alexander VJ, Prohaska TA, et al
   Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk.
   N Engl J Med. 2025 Nov 8. doi: 10.1056/NEJMoa2512761.
   PubMed     Abstract available
   
   
   April 2025
10. WATTS GF, Hegele RA, Leeper NJ
    Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk. Reply.
    N Engl J Med. 2025;392:1452-1453.
    PubMed    
    
    
    
11. SHIMAZU Y
    Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
    N Engl J Med. 2025;392:1452.
    PubMed    
    
    
    January 2025
12. STITZIEL NO
    Reducing the Risk of Pancreatitis by Inhibiting APOC3.
    N Engl J Med. 2025;392:197-199.
    PubMed    
    
    
    November 2024
13. GONDA TA, Cahen DL, Farrell JJ
    Pancreatic Cysts. Reply.
    N Engl J Med. 2024;391:2064.
    PubMed    
    
    
    
14. HAMADA T, Oyama H, Nakai Y
    Pancreatic Cysts.
    N Engl J Med. 2024;391:2063-2064.
    PubMed    
    
    
    September 2024
15. GONDA TA, Cahen DL, Farrell JJ
    Pancreatic Cysts.
    N Engl J Med. 2024;391:832-843.
    PubMed    
    
    
    
16. RUBIN EJ, Leopold J, Morrissey S
    NEJM at ESC - Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
    N Engl J Med. 2024 Sep 2. doi: 10.1056/NEJMe2410905.
    PubMed    
    
    
    
17. WATTS GF, Rosenson RS, Hegele RA, Goldberg IJ, et al
    Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
    N Engl J Med. 2024 Sep 2. doi: 10.1056/NEJMoa2409368.
    PubMed     Abstract available
    
    
    April 2024
18. STROES ESG, Alexander VJ, Karwatowska-Prokopczuk E, Hegele RA, et al
    Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
    N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2400201.
    PubMed     Abstract available
    
    
    February 2024
19. ALEXANDER VJ, Karwatowska-Prokopczuk E, Prohaska TA, Li L, et al
    Volanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia.
    N Engl J Med. 2024;390:476-477.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum